Vaccine trials generally proceed through several phases:
Phase I: Small groups receive the vaccine to test safety and dosage. Phase II: The vaccine is given to a larger group to further assess safety and immunogenicity. Phase III: Thousands of participants are involved to test efficacy and gather more safety data. Phase IV: Post-marketing surveillance to monitor long-term effects.
